How Much Does Keytruda Cost?
Keytruda (Pembrolizumab) costs an average of $18,176 per Medicare Part D claim, with total Medicare spending of $7234.0M in the latest year. No generic alternative is currently available.
Key Data
| Metric | Value |
|---|---|
| Avg Cost Per Claim | $18,176 |
| Total Medicare Spending | $7234.0M |
| Total Claims | 398,000 |
| Beneficiaries | 82,000 |
| Generic Available | No |
| Year-Over-Year Change | +28.6% |
Keytruda (Pembrolizumab) costs an average of $18,176 per Medicare Part D claim, with total Medicare spending of $7234.0M in the latest year. No generic alternative is currently available.